Medical Mycology – Page 7

Is metabolic generalism the Breakfast of Champions for pathogenic Candida species?

mycolabadmin

This review examines how different Candida species, including the common cause of yeast infections (C. albicans) and the more dangerous bloodstream pathogen (C. glabrata), survive in the human body. While most pathogenic Candida species are metabolic generalists that can eat many different nutrients, the review shows that C. glabrata is a specialist that has found alternative strategies to thrive. Understanding these metabolic strategies is important for developing better treatments and fighting antifungal resistance.

Spread of Antifungal-Resistant Trichophyton indotineae, United Kingdom, 2017–2024

mycolabadmin

A highly resistant fungal infection called Trichophyton indotineae is rapidly spreading throughout the United Kingdom. Originally from southern Asia, this fungus causes difficult-to-treat skin infections, particularly in the groin area, and resists standard antifungal medications in about three-quarters of cases. Since 2023, cases have spread from London to other parts of the UK and Ireland, and experts predict it will soon become the leading cause of ringworm in the country.

Paratracheal abscess by plant fungus Chondrostereum purpureum- first case report of human infection

mycolabadmin

A plant scientist in India developed an unusual infection caused by a fungus that normally only affects plants. The infection formed an abscess near his windpipe and caused voice problems and difficulty swallowing. Doctors couldn’t identify the fungus using standard methods, requiring DNA testing to confirm it was Chondrostereum purpureum, a fungus known to cause silver leaf disease in roses and other plants. The patient recovered completely after surgery to drain the abscess and antifungal medication for two months.

Multilocus sequence typing of Candida albicans isolates from wild and farm animals from southern Italy

mycolabadmin

Researchers studied a fungal pathogen called Candida albicans found in farm and wild animals in Italy to understand how it spreads between animals and humans. They used genetic analysis to compare isolates from laying hens, wild boars, and lizards with samples from infected humans around the world. The results showed that animal isolates were genetically similar to human clinical samples, suggesting animals could serve as reservoirs for this infection. This research highlights the importance of monitoring fungal diseases in animal populations as part of understanding disease transmission between animals and people.

Fungal pathogens and symbionts: Living off the fat of the land

mycolabadmin

Certain fungi that live exclusively in or on hosts have evolved a clever survival strategy: they stopped making their own fatty acids and instead steal them from their hosts. This includes fungi that cause pneumonia in immunocompromised patients, yeasts on skin, and beneficial fungi that help plants absorb nutrients from soil. By examining how these fungi scavenge fatty acids from their hosts, scientists hope to develop better treatments and diagnostic tools for fungal infections.

Drug repurposing to fight resistant fungal species: Recent developments as novel therapeutic strategies

mycolabadmin

This editorial highlights the growing problem of fungal infections that resist current treatments, causing millions of deaths worldwide each year. Researchers are finding new ways to fight these resistant infections by repurposing existing drugs in new combinations and discovering novel compounds from natural sources. The collection of studies presented shows promising results using combinations like minocycline with antifungal drugs, natural compounds like baicalin, and AI technology to predict resistance patterns. These innovative approaches offer hope for better treatment options for patients suffering from serious fungal infections.

Effects of simulated microgravity on biological features and virulence of the fungal pathogen Cryptococcus neoformans

mycolabadmin

Scientists studied how a dangerous fungus called Cryptococcus neoformans behaves in space-like conditions. They found that in simulated microgravity, the fungus becomes more dangerous by developing thicker protective capsules and producing more melanin, while also becoming more resistant to certain stresses. Interestingly, the fungus became more sensitive to one antifungal drug but maintained resistance to others. When tested on microscopic worms, the fungus grown in simulated microgravity killed them more quickly, suggesting space conditions could make this fungus more harmful to astronauts.

Mucor germinans, a novel dimorphic species resembling Paracoccidioides in a clinical sample: questions on ecological strategy

mycolabadmin

Researchers discovered a new fungus called Mucor germinans that infected a cancer patient’s lungs and appeared as yeast cells rather than the typical thread-like fungal structures. This is unusual because Mucor infections normally show filamentous hyphae, and the yeast-like appearance made it look like a different fungus, potentially delaying correct diagnosis and treatment. The study shows that this fungus can change forms depending on temperature and other conditions, and identifying it requires checking for multiple nuclei in the cells to distinguish it from other similar-looking yeasts.

Inferring fungal growth rates from optical density data

mycolabadmin

Scientists have developed a new mathematical method that allows doctors and lab technicians to measure fungal growth rates more accurately using simple optical density measurements. This approach doesn’t require expensive equipment or specialized knowledge, making it accessible to regular medical labs. The method could help doctors better assess how well antifungal drugs are working and detect resistant infections earlier.

Distribution of fungal agents in the respiratory system of patients with underlying lung diseases; molecular identification and antifungal susceptibility profiles

mycolabadmin

This research examined fungal infections in hospitalized patients with lung diseases in Iran, identifying which fungi were most common and which antifungal medications worked best against them. Researchers found that Candida albicans and Aspergillus flavus were the most prevalent fungi, particularly in COPD patients. Notably, some Candida isolates showed resistance to certain antifungal drugs, particularly voriconazole. The study emphasizes the importance of proper fungal identification and susceptibility testing for effective treatment.

Research Topic: Medical Mycology